conversion_pathBuying guide

How to Get Epithalon

Five routes ranked by friction alone, from forty minutes of reading to a phone call that ends in nothing, and then an honest look at why friction is the wrong ranking.

How to get epithalon splits into five routes, and they differ far more in what they ask of you than in what they deliver. Ranked by friction alone, the order is surprising, and the surprise is the useful part.

Friction here means effort you personally spend: minutes reading, appointments attended, forms filled, uncertainty carried. It is deliberately not a quality ranking, and the last section explains why the two come apart. Everything described is research material for laboratory use and not for human consumption, and the supplier links below are affiliate links.

The route at the bottom of the friction scale is a listing like this one, so it is worth seeing before the comparison starts.

Where the order actually gets placed

Ascension Peptides, Epithalon

US-based and third-party tested. Enter the code on the payment step and the vial halves before you confirm.

CodePEPTIDEDECK50% off

Epithalon · 10 mg$50.00$25.00Get the 10 mg →

The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.

Two batch certificates per lot
Shipping free over $250
Out the door same day if you order before 2pm CST

Everything here is research material for laboratory use, not for human consumption. Affiliate links, so we may earn a commission at no cost to you. Prices last checked August 23, 2026.

How to get epithalon: five routes, ranked by friction alone

The domestic research listing. Roughly forty minutes of your time, once.
The reseller or group buy. Ten minutes, and an unanswerable question afterwards.
The longevity clinic. An appointment, an intake, and two to four weeks of calendar.
The overseas marketplace. Weeks of waiting, plus customs, duty and no recourse.
The prescription. Unlimited friction, because the route does not complete.

The forty minutes: a domestic research listing

Almost all the effort in this route sits before the payment, and it is the only route where effort spent up front buys you anything.

Thirty of those minutes belong to one document. The certificate for batch 15-05260628, report KVR-2026-A36FF4 from Kovera Labs, certified 05/23/2026, is a single page that answers five separate questions. Purity is 99.312% against a specification of 98 percent or better, measured by RP-HPLC on a C18 column with detection at 214 nm. Identity is confirmed by LC-MS. An endotoxin safety screen passes against a limit of 0.5 EU/mL, a microbial sterility screen returns no growth, and heavy metals screening comes back negative for arsenic, cadmium, lead and mercury.

The fifth answer is the one worth slowing down for. Net content is reported as 9.64 mg in a vial labelled 10 mg, with the specification written as 10 mg plus or minus 10 percent. Inside tolerance, under the label, and printed anyway. It shifts the honest price on that batch from $2.50 per milligram to $2.59, which is a number no seller has a reason to volunteer.

The other ten minutes are ordinary commerce. The vial lists at $50.00, reduced from $69.99, and the code PEPTIDEDECK takes it to $25.00. Quantity tiers of 3, 5 or 10 take 3%, 5% or 10% off list, with nothing published to say the code stacks with them. Free shipping starts at $250. Orders placed before 2pm CST go out the same day, and from there the clock belongs to a carrier rather than to you.

The ten minutes: a reseller, a group buy, a direct message

This is the least demanding route in the literal sense, and pretending otherwise would be dishonest. There is no account to make, no document to read and no cutoff to beat. Material arrives decanted into an unlabelled vial, often within days.

What it asks instead is that you hold a question you can never close. Decanting severs the link between the material and any lot number, which means no certificate can describe what you received, including a genuine one belonging to the original bulk. A screenshot does not repair it and neither does a good reputation on a forum, because the thing being vouched for is not the thing being tested.

The second cost is continuity. Sellers in this route rotate constantly, and consistency between orders is the only informal signal available to someone who cannot test material. A route with no reorder path has no signal at all.

The appointment: a longevity or anti-ageing practice

Epithalon is one of the few research peptides with a real clinic channel, which is why so many people searching where to get epithalon find a practice before they find a listing.

The friction is front-loaded and calendar-shaped. An intake appointment, frequently a panel of bloodwork, a programme rather than a product, and two to four weeks before the first of those happens. None of that waiting is caused by the compound.

The thing to watch here is the claim rather than the queue. This substance is marketed on telomere and longevity arguments that rest largely on Russian-language work from one research group in St Petersburg, and a consulting room is a persuasive room. Reporting that the claims exist is accurate. Treating a clinical setting as evidence for them is not. The three questions that cut through it are which laboratory tested the batch, what the report covered, and whether you can see it, and they take about a minute to ask.

The weeks: an overseas marketplace

Here the friction is not effort so much as exposure. Ordering is easy. Everything after it is not.

FDA's personal importation guidance treats unapproved drugs as generally subject to refusal, so the parcel carries a real chance of not arriving. UK and EU buyers pay VAT and a carrier handling fee on delivery, which lands after the purchase rather than during it. Transit is usually the short part of the wait and clearance the long one, and clearance has a binary outcome rather than a slow one.

The certificate problem here is structural. Bulk sellers commonly publish one document per product instead of one per lot, so the paper describes material that is not yours. That is a different failure from having no document, and it is worse, because it looks like evidence.

The route that does not complete

Anyone hoping for a prescription is looking for a door that has not been built, and the reasoning is specific enough to be worth carrying.

Epitalon, as FDA and PubChem spell it, has no FDA approval for any indication. It has no applicable USP monograph and is not a component of an approved drug, and it is not on the 503A bulks list. It was nominated for that list, sat in category 2 under the interim policies, and the nomination was then withdrawn before any determination was reached, which is why it appears today in FDA's table of bulk drug substances nominated but withdrawn on a page current as of 04/22/2026. It is on no current category list.

FDA's stated concern is not a technicality either. The agency writes that compounded drugs containing epitalon may pose a risk of immunogenicity for certain routes of administration because of potential aggregation and peptide-related impurities, and that it lacks sufficient information to know whether the drug would cause harm if administered to humans. Nothing was decided, and that is precisely the problem.

The practical consequence is that a prescriber has nowhere lawful to send a script, so calls to pharmacies end quickly. A pharmacy that agrees anyway has told you something about itself rather than about the compound.

Why friction is the wrong ranking, and where people actually land

Read the list again and the flaw is obvious. The two easiest routes are first and second, and one of them is the only route where the material can be documented while the other is the only route where it structurally cannot. Friction measures what a route costs you today. It says nothing about what the route can prove.

Reorder the same five on evidence and the domestic listing stays first and everything else moves down. That agreement between two different rankings is the reason most people who start with a search for how to get epitalon end up at a research supplier: not because it is easiest, though it nearly is, but because it is the only route where the first ranking and the second one point the same way.

What lands, if you take it, is a small sealed glass vial holding a white lyophilised cake, a red cap and a silver crimp, a label carrying the compound name, quantity and lot number, and nothing implying human use. Sealed lyophilised vials are stored cold and dark, so the only preparation the delivery genuinely requires is somewhere to put it.

Common questions

Common Concerns

Is there any prescription route in the United States?expand_more

No ordinary one, and the reason is specific rather than general. A 503A pharmacy compounding from a bulk substance needs that substance to have an applicable USP monograph, to be a component of an FDA-approved drug, or to appear on the 503A bulks list. Epitalon meets none of those conditions, and its nomination for that list was withdrawn before FDA reached any determination, so it now appears in the agency's table of substances nominated but withdrawn rather than on any current category list. A prescriber who wanted to write for it would find nothing lawful to send it to.

Why is the grey market ranked as low friction if the page advises against it?expand_more

Because friction and quality are two different measurements, and separating them is the point of the ranking. A reseller who ships in three days with no account and no questions is genuinely the path of least resistance. What it costs is the only thing in this market that can be independently checked, since decanted material has no chain back to a lot number and no certificate can be attached to it afterwards. Ranking it honestly on friction is what makes the trade visible instead of hiding it behind a warning.

How much of a week does the lowest-friction route actually consume?expand_more

About forty minutes of your attention, and then nothing. Twenty to thirty minutes reads the certificate properly, including the specification column beside each result rather than the results alone. Five minutes covers the cart, the code and the payment step. After that the parcel is a carrier's problem and there is nothing left for you to do until it arrives. The remaining days are elapsed time rather than effort, which is the distinction the ranking is built on.

What should someone ask a longevity clinic before booking?expand_more

Which laboratory tested the batch they would supply, what the report covered, and whether you can read it. Those three questions take a minute on the phone and they sort the practices that hold documented material from the ones repeating a brochure. It is also worth noticing what the marketing is claiming, because this compound is sold on telomere and lifespan arguments resting largely on Russian-language work from one research group, and a consulting room does not upgrade that evidence.

Does buying from overseas save money in practice?expand_more

On the headline reliably, on the total rarely. Gram pricing looks decisive next to a 10 mg vial until international shipping, VAT and carrier handling charges are added for UK and EU buyers, and until the possibility of a border stop is priced in. FDA's personal importation guidance treats unapproved drugs as generally subject to refusal, so a percentage of these orders simply do not complete. A reorder after a seizure doubles both the wait and the cost, which erases the saving on its own.

Does any of this mean the substance has been shown to be safe?expand_more

No, and no route changes that. Epithalon has no FDA approval anywhere in the West. FDA's published position is that compounded drugs containing epitalon may pose a risk of immunogenicity for certain routes of administration because of potential aggregation and peptide-related impurities, and that it lacks the information to know whether the substance would cause harm if administered to humans. A batch certificate answers what is in a vial. It does not answer that question, and nothing sold through any of these five routes does.

Keep exploring

The same five routes for a compound sitting in the identical withdrawn-nomination position, with no clinic channel to complicate it, are laid out in the Selank routes and the dead end at the end of one of them. Where a clinic is the mainstream option rather than the unusual one, the NAD+ comparison between weeks of asking and minutes of checking inverts the ranking. And the NAD+ status, which is genuinely still under review is the useful contrast to a nomination that was pulled.